Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/25/2869465/0/en/Eyenovia-Provides-Clinical-and-Scientific-Update-on-FDA-Approved-Products-Mydcombi-and-Clobetasol-Propionate-Ophthalmic-Suspension.html
https://www.globenewswire.com/news-release/2024/04/08/2859046/0/en/Eyenovia-Announces-Updated-Strategy-and-Corporate-Priorities-to-Focus-on-Shareholder-Value-Generation-and-Immediate-Commercial-Opportunities.html
https://www.globenewswire.com/news-release/2024/04/03/2856771/0/en/Eyenovia-to-Feature-its-Suite-of-Commercial-Products-and-the-Optejet-Dispenser-at-Upcoming-National-Eyecare-Meetings.html
https://www.globenewswire.com/news-release/2024/03/18/2848151/0/en/Eyenovia-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provides-Business-Update.html
https://www.globenewswire.com/news-release/2024/03/18/2848151/0/en/Eyenovia-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provides-Business-Update.html
https://www.globenewswire.com//news-release/2024/03/13/2845282/0/en/NovaBay-Pharmaceuticals-and-Eyenovia-to-Co-Promote-Prescription-Ophthalmic-Products-to-U-S-Eyecare-Professionals.html
https://www.globenewswire.com//news-release/2024/03/11/2843602/0/en/Eyenovia-to-Report-Fourth-Quarter-2023-Results-and-Provide-Business-Update-on-Monday-March-18th.html
https://www.reuters.com/business/healthcare-pharmaceuticals/gsks-new-hiv-drug-formula-could-support-longer-dosing-intervals-2024-03-04/
https://www.globenewswire.com//news-release/2024/02/13/2828089/0/en/Eyenovia-Announces-FDA-Approval-of-Redwood-City-as-Commercial-Manufacturing-Facility.html
https://www.globenewswire.com//news-release/2024/01/16/2809702/0/en/Eyenovia-Re-Acquires-Development-and-Commercialization-Rights-to-MicroPine-in-the-U-S-and-Canada.html